Adenomyosis in Iraq: a preliminary report

Rawaa D. ALJANABI, Eman A. Al-Kaseer, Jawad K. Al-Diwan
In: Chirurgia · 2026 · vol. 39(2) · doi:10.23736/s0394-9508.24.05852-2 · W7143899663
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

This study investigated the frequency of adenomyosis in 100 women with abnormal uterine bleeding in Iraq, finding a 29% diagnosis rate consistent with regional averages.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-17 · read from full text ⓘ

This preliminary report investigated the prevalence of adenomyosis among women presenting with abnormal uterine bleeding in Iraq. The study enrolled 100 patients who underwent hysteroscopic examination and biopsies, resulting in a diagnosis of adenomyosis for 29% of the cohort. These findings align with the reported global prevalence range and are consistent with the average rate observed in the Middle East. This paper is centrally about adenomyosis, specifically examining its frequency as a cause of irregular uterine hemorrhage in an Iraqi population.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Adenomyosis is the aberrant infiltration of endometrial glandular tissue into the uterine myometrium, resulting in symptoms such as menorrhagia, severe cramping, and dyspareunia. This study sought to determine the frequency of adenomyosis in women with abnormal uterine bleeding in Iraq. METHODS: The study comprised 100 women with atypical uterine bleeding, and data was gathered by direct interviews. Each patient underwent hysteroscopic examination and biopsies. Of the total, 29% were diagnosed with adenomyosis. RESULTS: The projected global prevalence of adenomyosis in consecutive hysterectomy patients varied between 8.8% and 61.5%. The observed rate fell within the reported range of the Middle East’s average of 30.8%. CONCLUSIONS: Consequently, adenomyosis is a significant etiology of irregular uterine hemorrhage.
Full text 1,718 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Background

Adenomyosis is the aberrant infiltration of endometrial glandular tissue into the uterine myometrium, resulting in symptoms such as menorrhagia, severe cramping, and dyspareunia. This study sought to determine the frequency of adenomyosis in women with abnormal uterine bleeding in Iraq.

Methods

The study comprised 100 women with atypical uterine bleeding, and data was gathered by direct interviews. Each patient underwent hysteroscopic examination and biopsies. Of the total, 29% were diagnosed with adenomyosis.

Results

The projected global prevalence of adenomyosis in consecutive hysterectomy patients varied between 8.8% and 61.5%. The observed rate fell within the reported range of the Middle East’s average of 30.8%.

Conclusions

Consequently, adenomyosis is a significant etiology of irregular uterine hemorrhage. KEY WORDS: Adenomyosis; Menorrhagia; Iraq

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosisdyspareunia

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

References (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-06T06:31:40.515551+00:00
License: CC0 · commercial use OK